Track the Lifeward Ltd. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €21.2m. The latest transaction was reported on 28 August 2026 (Attribution). Among the most active insiders: Swinford Michael. All data is free.
23
Insider Decl.
n/a
Thresholds
€109,544
4 ops.
Buy Volume
€261,119
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Lifeward Ltd. Strong Buy (bullish), based on 2 analysts. Average price target: US$20.00.
35Σ signal
Buys €109,544€261,119 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,435 of 29,062 companies
10.2
score / 100
Value
2
Quality
18
FCF yld-80%
Earn yld-94%
EV/EBITDA·
ROE-226%
Gross mgn38%
Net mgn-90%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,672 shares@ US$3.256100.0% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0001062993-24-016656:0
23 of 23 declarations
Acerca de Lifeward Ltd.
Lifeward Ltd. es una empresa que cotiza en el mercado XNAS, especializada en el desarrollo de soluciones innovadoras para el sector de la salud. Se enfoca en mejorar la calidad de vida de los pacientes a través de tecnologías avanzadas.